Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
May 15, 2026
Reporting period
Not applicable
Filed with the SEC
May 19, 2026
OfficerTax withholding
Context
Classification
tax withholding
Code F — shares delivered to pay exercise price or tax liability
Planned / mechanical clue
Tax mechanics (code F)
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0000313143-26-000044
Filed / recorded
May 19, 2026, 9:31 PM UTC
Added to OQRO
Oct 6, 2026, 7:59 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
HAEMONETICS CORP
Issuer CIK
313143
Ticker
HAE
Reporting person
Roy Galvin
Relationship
Officer
Officer title
EVP, Chief Commercial Officer
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
May 15, 2026
Transaction code
F
Shares / units
879
Price per share
$56.29
Acquired / disposed
Disposed (D)
Shares owned after
12,347
Ownership form
Direct
Amendment
No
Footnotes from the filing
Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.
This number includes unvested RSUs previously reported as well as 415 shares acquired by the reporting person under the Haemonetics Corporation 2007 Employee Stock Purchase Plan (as amended and/or restated from time to time) on April 30, 2026.